Haya Therapeutics' Incubator/Accelerator - II Round

Haya Therapeutics raised a round of funding on November 27, 2017. Investors include Startlab Biopole.

Haya Therapeutics is developing a therapeutic approach to combat heart failure and fibrosis.…

Articles about Haya Therapeutics' Incubator/Accelerator - II Round: